Tumors treated with LV-shCCT3 exhibited significantly impaired staining of CCT3 compared with the control groups (Figure 5D), suggesting that CCT3 knockdown inhibited melanoma cell tumorigenicity in vivo. Here, CCT3 is linked to melanoma.